BioCentury | Jul 22, 2019
Clinical News

July 22 Clinical Quick Takes: Positive psoriasis data for Arcutis; plus Intec and Renovo

...data from ACCORDANCE's to determine next steps. Renovo planning another Phase IIb of gene therapy RT-100...
...Renova Therapeutics (San Diego, Calif.) now plans to run another Phase II study of RT-100 (Ad5.hAC6...
...Adenylate cyclase 6; PDE-4 - Phosphodiesterase-4 Sandi Wong, Staff Writer Accordion Pill Carbidopa/Levodopa, carbidopa/levodopa gr (AP-CD/LD) Ad5.hAC6 (RT-100) Arcutis...
BioCentury | Jan 19, 2018
Clinical News

Renova to begin Phase III of RT-100 in heart failure

...said it will start this quarter the Phase III FLOURISH trial of gene therapy RT-100 (Ad5.hAC6...
...a Phase II trial of RT-100 in the indication (see BioCentury, April 4, 2016 ). RT-100...
...U.S. to treat heart failure with reduced LVEF. Renova Therapeutics, San Diego, Calif. Product: RT-100 (Ad5.hAC6...
BioCentury | Oct 6, 2016
Product R&D

Encoding glucose control

...search to bypass the peaks and troughs of standard therapies. Renova's lead product RT-100 ( Ad5.hAC6...
BioCentury | Apr 4, 2016
Clinical News

Ad5: Phase II data

...Top-line combined data from the 2 highest dose groups of RT-100 in a double-blind, U.S. Phase...
...in 56 symptomatic heart failure patients with an ejection fraction of <=40% showed that intracoronary RT-100...
...pivotal trials of RT-100 in CHF. Renova Therapeutics , San Diego, Calif. Product: Ad5.hAC6 ( RT-100...
BioCentury | Mar 31, 2016
Clinical News

Renova raising funds for pivotal gene therapy trials

...San Diego, Calif.) plans to begin three pivotal studies by YE16 of gene therapy candidate RT-100...
...to heart muscle cells. The Phase II trial evaluated 42 patients receiving single doses of RT-100...
Items per page:
1 - 5 of 5